Perceptive Advisors’s Enzymotec Ltd ENZY Stock Holding History

Perceptive Advisors’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-214,219	Closed	-$4.72M	–	161
2014 Q1	$4.72M	Buy	+214,219	New	+$5.68M	0.5%	46

Other funds holding ENZY

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

MCM

Matterhorn Capital Management San Antonio, Texas $151M AUM 14.72% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

MACM

March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors's ENZY Position: Q2 2014 in Review

Perceptive Advisors sold out of Enzymotec Ltd (ENZY) in Q2 2014, closing a stake of 214,219 shares — an estimated $4.72M sold.

Perceptive Advisors first reported a position in ENZY in Q1 2014 and held it in 1 quarter. The position peaked at $4.72M in Q1 2014. 25 funds tracked by Wall St. Rank hold ENZY as of Q2 2014.

Perceptive Advisors reported no remaining Enzymotec Ltd position as of Q2 2014 after selling out during the quarter.
Perceptive Advisors sold 214,219 Enzymotec Ltd shares in Q2 2014, an estimated $4.72M.
Perceptive Advisors first reported a position in Enzymotec Ltd in Q1 2014 and held it in 1 quarter.
Perceptive Advisors's Enzymotec Ltd position peaked at $4.72M in Q1 2014.
25 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2014.

Based on Perceptive Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.